No article text was recorded for this version.
chemotherapy drug resistance
Version 1 of 118 papers22 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption
- Blog: Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies
- Blog: [The targets research of non-small cell lung cancer targeted therapy].
- Blog: Deep graph embedding for prioritizing synergistic anticancer drug combinations
- Blog: Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation
- Blog: PLK1 overexpression as a dual-role biomarker and therapeutic vulnerability in pulmonary adenocarcinoma
- Blog: Reversal of Multidrug Resistance by the Chinese Medicine Yiqi Jianpi Huaji Decoction and the Mechanism of Action in Human Gastric Cancer SGC7901/VCR Cells
- Blog: Jianpi Bushen, a Traditional Chinese Medicine Therapy, Combined with Chemotherapy for Gastric Cancer Treatment: A Meta‐Analysis of Randomized Controlled Trials
- Blog: Real-world outcomes of trastuzumab deruxtecan in HR-negative HER2-low metastatic breast cancer
- Blog: Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming
- Blog: Advances in Therapeutic Implications of Inorganic Drug Delivery Nano-Platforms for Cancer
- Blog: GDC-0941 activates integrin linked kinase (ILK) expression to cause resistance to GDC-0941 in breast cancer by the tumor necrosis factor (TNF)-α signaling pathway
- Blog: Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway.
- Blog: Gas Plasma Combination Therapies—Promises from Preclinical Oncology Research
- Blog: From Blood to Therapy: The Revolutionary Application of Platelets in Cancer-Targeted Drug Delivery
- Blog: Doxorubicin‐Loaded Metal–Organic Framework for Ferroptosis‐Enhanced Chemotherapy Through Sustained Zn Release and Glutathione Peroxidase Downregulation
- Blog: Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
- Blog: Meta-Analysis of Paclitaxel-Based Chemotherapy Combined With Traditional Chinese Medicines for Gastric Cancer Treatment
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_chemotherapy_drug_resistance_68a3e29e,
title = {chemotherapy drug resistance},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/chemotherapy-drug-resistance/rdr_68a3e29e049e435b9cbb44f0455dec7e},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_chemotherapy_drug_resistance_68a3e29e_v1,
title = {chemotherapy drug resistance},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/chemotherapy-drug-resistance/rdr_68a3e29e049e435b9cbb44f0455dec7e/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}